Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

One-Time artery fix may cut hospital time for heart attack patients

NCT ID NCT07519590

Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two ways to treat heart attack patients who have multiple blocked arteries. One group had all blockages fixed in a single procedure, while the other group had the main blockage fixed first and the others in a separate procedure later. The goal was to see if the one-time approach could reduce hospital stays and costs without causing more problems. The study involved 112 adults who had a specific type of heart attack and were treated with a clot-busting drug before the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Percutaneous coronary intervention (PCI) procedure
What this could lead to
If successful, this approach could shorten hospital stays and lower costs for heart attack patients with multiple blocked arteries, without increasing short-term risks.
What could go wrong
This is a small, completed study with 112 participants, so results may not apply to all patients. There is a risk of kidney damage from contrast dye, and long-term benefits are not yet clear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

112 people

The number who actually took part.

Started

Apr 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults older than 18 years. * Acute ST-elevation myocardial infarction treated with a pharmaco-invasive strategy. * Successful fibrinolysis followed by coronary angiography and percutaneous coronary intervention. * Multivessel coronary artery disease. * Ability to provide written informed consent. Exclusion Criteria: * Primary percutaneous coronary intervention. * Unsuccessful fibrinolysis requiring rescue percutaneous coronary intervention. * Candidacy for coronary artery bypass grafting after angiography. * Failed complete revascularization. * Cardiogenic shock. * Single-vessel coronary artery disease treated with a pharmaco-invasive strategy. * Stent thrombosis. * Chronic total occlusion. * Planned percutaneous transluminal coronary angioplasty to a non-culprit lesion in a vessel smaller than 2.5 millimeters with more than 70 percent stenosis. * Severe valvular heart disease. * Pregnancy. * Prior cardiac surgery. * Congenital heart disease. * Severe hepatic impairment. * Severe renal impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Myocardial infarction

Contacts and locations

Locations

  • Helwan University Hospital

    Cairo, Cairo Governorate, 11795, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.